Monica K VanKlompenberg Selected Research

Tics (Tic)

11/2017

APC loss in breast cancer leads to doxorubicin resistance via STAT3 activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Monica K VanKlompenberg Research Topics

Disease

3	Breast Neoplasms (Breast Cancer) 01/2021 - 06/2015
2	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 01/2021 - 11/2017
2	Neoplasms (Cancer) 01/2021 - 06/2015
1	Tics (Tic) 11/2017
1	Carcinogenesis 06/2015

Drug/Important Bio-Agent (IBA)

2	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 06/2015
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2017 - 06/2015
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 11/2017 - 06/2015
2	Cisplatin (Platino)FDA LinkGeneric 11/2017 - 06/2015
1	taxaneIBA 01/2021
1	Taxoids (Taxanes)IBA 01/2021
1	pyrazolanthroneIBA 06/2015
1	ATP-Binding Cassette Transporters (ABC Transporters)IBA 06/2015
1	CateninsIBA 06/2015
1	Focal Adhesion Protein-Tyrosine KinasesIBA 06/2015
1	Tumor Viral Antigens (Large T Antigen)IBA 06/2015

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 01/2021 - 11/2017
1	Therapeutics 01/2021